News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Graves Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 16,253 options to buy
@ $26, valued at
$422.6k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $59.795, valued at
$598k
|
|
| 01/25/2019 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $42.4, valued at
$424k
|
|
| 01/09/2018 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $59.14, valued at
$591.4k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/04/2016 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $46.66, valued at
$699.9k
|
|
| 03/16/2016 |
4
| Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $56.73, valued at
$56.7k
|
|
|
|